Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

166 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Kinetics of cellular and humoral immunogenicity and effectiveness of SARS-CoV-2 booster vaccination in hematologic neoplasms.
Jiménez M, Fernández-Naval C, Navarro V, Novoa S, Martinez-Gallo M, Medina D, Andrés C, Antón A, Peralta S, Pujadas G, Hernández C, Pagès C, Roldán E, Pumarola T, Gironella M, Ruiz-Camps I, Martínez-Gómez X, Valcárcel D, Hernández M, Bosch F, Crespo M, Esperalba J, Abrisqueta P. Jiménez M, et al. Among authors: pages c. Am J Hematol. 2023 Aug;98(8):1204-1213. doi: 10.1002/ajh.26951. Epub 2023 May 8. Am J Hematol. 2023. PMID: 37151135
Sample CME manuscript submission: Response to the article by Pham et al entitled "Review BRAF inhibition and the spectrum of granulomatous reactions".
Marcaillou M, Dion J, Baroudjian B, Ezrine E, Carrera C, Anderle A, Apalla Z, Freites-Martinez A, Pages C, Lebbe C, Meyer N, Sibaud V, Comont T. Marcaillou M, et al. Among authors: pages c. J Am Acad Dermatol. 2022 Aug;87(2):e85-e88. doi: 10.1016/j.jaad.2022.04.053. Epub 2022 May 5. J Am Acad Dermatol. 2022. PMID: 35526651 No abstract available.
Autoimmune Skin Diseases and Immune Checkpoint Inhibitors.
Fattore D, Potestio L, Genco L, Pages C, Ortiz A, Fabbrocini G, Sibaud V. Fattore D, et al. Among authors: pages c. Crit Rev Immunol. 2022;42(3):11-22. doi: 10.1615/CritRevImmunol.2023047032. Crit Rev Immunol. 2022. PMID: 37017623 Review.
Cellular and humoral immunogenicity of the mRNA-1273 SARS-CoV-2 vaccine in patients with hematologic malignancies.
Jiménez M, Roldán E, Fernández-Naval C, Villacampa G, Martinez-Gallo M, Medina-Gil D, Peralta-Garzón S, Pujadas G, Hernández C, Pagès C, Gironella M, Fox L, Orti G, Barba P, Pumarola T, Cabirta A, Catalá E, Valentín M, Marín-Niebla A, Orfao A, González M, Campins M, Ruiz-Camps I, Valcárcel D, Bosch F, Hernández M, Crespo M, Esperalba J, Abrisqueta P. Jiménez M, et al. Among authors: pages c. Blood Adv. 2022 Feb 8;6(3):774-784. doi: 10.1182/bloodadvances.2021006101. Blood Adv. 2022. PMID: 34844263 Free PMC article.
166 results